{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T20:58:56Z","timestamp":1794344336086,"version":"4.9.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Oliceridine is a G protein\u2013biased \u00b5-opioid, a drug class that is associated with less respiratory depression than nonbiased opioids, such as morphine. The authors quantified the respiratory effects of oliceridine and morphine in elderly volunteers. The authors hypothesized that these opioids differ in their pharmacodynamic behavior, measured as effect on ventilation at an extrapolated end-tidal P\n                      <jats:sc>co<\/jats:sc>\n                      <jats:sub>2<\/jats:sub>\n                      at 55 mmHg, V\u0307\n                      <jats:sub>E<\/jats:sub>\n                      55.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This four-arm double-blind, randomized, crossover study examined the respiratory effects of intravenous 0.5 or 2 mg oliceridine and 2 or 8 mg morphine in 18 healthy male and female volunteers, aged 55 to 89 yr, on four separate occasions. Participants\u2019\n                      <jats:italic toggle=\"yes\">CYP2D6<\/jats:italic>\n                      genotypes were determined, hypercapnic ventilatory responses were obtained, and arterial blood samples were collected before and for 6 h after treatment. A population pharmacokinetic\u2013pharmacodynamic analysis was performed on V\u0307\n                      <jats:sub>E<\/jats:sub>\n                      55, the primary endpoint; values reported are median \u00b1 standard error of the estimate.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Oliceridine at low dose was devoid of significant respiratory effects. High-dose oliceridine and both morphine doses caused a rapid onset of respiratory depression with peak effects occurring at 0.5 to 1 h after opioid dosing. After peak effect, compared with morphine, respiratory depression induced by oliceridine returned faster to baseline. The effect-site concentrations causing a 50% depression of V\u0307\n                      <jats:sub>E<\/jats:sub>\n                      55 were 29.9 \u00b1 3.5 ng\/ml (oliceridine) and 21.5 \u00b1 4.6 ng\/ml (morphine), the blood effect-site equilibration half-lives differed by a factor of 5: oliceridine 44.3 \u00b1 6.1 min and morphine 214 \u00b1 27 min. Three poor\n                      <jats:italic toggle=\"yes\">CYP2D6<\/jats:italic>\n                      oliceridine metabolizers exhibited a significant difference in oliceridine clearance by about 50%, causing higher oliceridine plasma concentrations after both low- and high-dose oliceridine, compared with the other participants.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Oliceridine and morphine differ in their respiratory pharmacodynamics with a more rapid onset and offset of respiratory depression for oliceridine and a smaller magnitude of respiratory depression over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Editor\u2019s Perspective<\/jats:title>\n                    <jats:sec>\n                      <jats:title>What We Already Know about This Topic<\/jats:title>\n                    <\/jats:sec>\n                    <jats:sec>\n                      <jats:title>What This Article Tells Us That Is New<\/jats:title>\n                    <\/jats:sec>\n                  <\/jats:sec>","DOI":"10.1097\/aln.0000000000004473","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T11:50:39Z","timestamp":1671537039000},"page":"249-263","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":43,"title":["Respiratory Effects of Biased Ligand Oliceridine in Older Volunteers: A Pharmacokinetic\u2013Pharmacodynamic Comparison with Morphine"],"prefix":"10.1097","volume":"138","author":[{"given":"Pieter","family":"Simons","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutger","family":"van der Schrier","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"van Lemmen","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Jansen","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiki W.K.","family":"Kuijpers","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"van Velzen","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Sarton","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Nicklas","sequence":"additional","affiliation":[{"name":"Trevena Inc., Chesterbrook, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Michalsky","sequence":"additional","affiliation":[{"name":"Trevena Inc., Chesterbrook, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Demitrack","sequence":"additional","affiliation":[{"name":"Trevena Inc., Chesterbrook, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fossler","sequence":"additional","affiliation":[{"name":"Trevena Inc., Chesterbrook, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Olofsen","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"Niesters","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3161-3945","authenticated-orcid":false,"given":"Albert","family":"Dahan","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Leiden University Medical Center, Leiden, The NetherlandsPainLess Foundation, Leiden, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,12,20]]},"reference":[{"key":"R1-20251014","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3390\/ph14111091","article-title":"Opioid analgesia and opioid-induced adverse effects: A review.","volume":"14","author":"Paul","year":"2021","journal-title":"Pharmaceut (Basel)."},{"key":"R2-20251014","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamasurg.2018.1039","article-title":"Association of opioid-related adverse drug events with clinical and cost outcomes among surgical patients in a large integrated health care delivery system.","volume":"153","author":"Shafi","year":"2018","journal-title":"JAMA Surg."},{"key":"R3-20251014","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/phar.1223","article-title":"Cost and quality implications of opioid-based postsurgical pain control using administrative claims data from a large health system: Opioid-related adverse events and their impact on clinical and economic outcomes.","volume":"33","author":"Kessler","year":"2013","journal-title":"Pharmacotherapy."},{"key":"R4-20251014","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.2174\/138161212803582469","article-title":"Non-analgesic effects of opioids: Opioid-induced respiratory depression.","volume":"18","author":"Boom","year":"2012","journal-title":"Curr Pharm Des."},{"key":"R5-20251014","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/cpt.2696","article-title":"Development of a translational model to assess the impact of opioid overdose and naloxone dosing on respiratory depression and cardiac arrest.","volume":"112","author":"Mann","year":"2022","journal-title":"Clin Pharmacol Ther."},{"key":"R6-20251014","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/ALN.0000000000003166","article-title":"Rational perioperative opioid management in the era of the opioid epidemic.","volume":"132","author":"Kharasch","year":"2020","journal-title":"Anesthesiology."},{"key":"R7-20251014","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/jcph.1076","article-title":"Oliceridine (TRV130), a novel G protein-biased ligand at the mu-opioid receptor, a predictable relationship between plasma concentrations and pain relief. I: Development of pharmacokinetic\/pharmacodynamic model.","volume":"58","author":"Fossler","year":"2018","journal-title":"J Clin Pharmacol."},{"key":"R8-20251014","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1124\/jpet.112.201616","article-title":"A G protein-biased ligand at the \u03bc-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine.","volume":"344","author":"Dewire","year":"2013","journal-title":"J Pharmacol Exp Ther."},{"key":"R9-20251014","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature19112","article-title":"Structure-based discovery of opioid analgesics with reduced side effects.","volume":"537","author":"Manglik","year":"2016","journal-title":"Nature."},{"key":"R10-20251014","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/jpet.105.087254","article-title":"Morphine side effects in \u03b2-arrestin 2 knockout mice.","volume":"314","author":"Raehal","year":"2005","journal-title":"J Pharmacol Ther."},{"key":"R11-20251014","doi-asserted-by":"crossref","first-page":"eaaz3140","DOI":"10.1126\/scisignal.aaz3140","article-title":"Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists.","volume":"13","author":"Gillis","year":"2020","journal-title":"Sci Signal."},{"key":"R12-20251014","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1021\/acs.biochem.1c00466","article-title":"Low intrinsic efficacy alone cannot explain the improved side effect profiles of new opioid agonists.","volume":"61","author":"Stahl","year":"2022","journal-title":"Biochemistry."},{"key":"R13-20251014","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/ALN.0000000000003441","article-title":"Benefit and risk evaluation of biased \u03bc-receptor agonist oliceridine versus morphine.","volume":"133","author":"Dahan","year":"2020","journal-title":"Anesthesiology."},{"key":"R14-20251014","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/j.pain.2014.06.011","article-title":"Biased agonism of the \u00b5-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects vs. morphine: A randomized, double-blind, placebo-controlled, crossover study in healthy volunteers.","volume":"155","author":"Soergel","year":"2014","journal-title":"Pain."},{"key":"R15-20251014","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/j.pain.0000000000000363","article-title":"A randomized, phase-2 study investigating TRV130, a biased-ligand of the mu-opioid receptor, for intravenous treatment of pain.","volume":"157","author":"Viscussi","year":"2016","journal-title":"Pain."},{"key":"R16-20251014","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/imj.1967.16.1.20","article-title":"A clinical method for assessing the ventilatory response to carbon dioxide.","volume":"16","author":"Read","year":"1967","journal-title":"Australas Ann Med."},{"key":"R17-20251014","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1378\/chest.70.1_Supplement.118","article-title":"Measurement of ventilatory response to CO2 by rebreathing.","volume":"70","author":"Rebuck","year":"1976","journal-title":"Chest."},{"key":"R18-20251014","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/jama.2022.17735","article-title":"Effect of paroxetine or quetiapine combined with oxycodone on ventilation: A randomized clinical trial.","volume":"328","author":"Florian","year":"2022","journal-title":"JAMA."},{"key":"R19-20251014","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s41398-021-01717-9","article-title":"Methodology for clinical genotyping of CYP2D6 and CYP2C19.","volume":"11","author":"Henriques","year":"2021","journal-title":"Transl Psychiatry."},{"key":"R20-20251014","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/ALN.0000000000001505","article-title":"Influence of ethanol on oxycodone-induced respiratory depression: A dose-escalating study in young and elderly volunteers.","volume":"126","author":"van der Schrier","year":"2017","journal-title":"Anesthesiology."},{"key":"R21-20251014","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/00000542-200310000-00008","article-title":"Pharmacodynamic effect of morphine-6-glucuronide versus morphine on hypoxic and hypercapnic breathing in healthy volunteers.","volume":"99","author":"Romberg","year":"2003","journal-title":"Anesthesiology."},{"key":"R22-20251014","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00003088-199630050-00001","article-title":"A size standard for pharmacokinetics.","volume":"30","author":"Holford","year":"1996","journal-title":"Clin Pharmacokinet."},{"key":"R23-20251014","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/bja\/aex295","article-title":"An experimental study comparing the respiratory effects of tapentadol and oxycodone in healthy volunteers.","volume":"119","author":"van der Schrier","year":"2017","journal-title":"Br J Anaesth."},{"key":"R24-20251014","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00000542-200308000-00014","article-title":"Using the maximum effect site concentration to combine pharmacokinetics and pharmacodynamics.","volume":"99","author":"Minto","year":"2003","journal-title":"Anesthesiology."},{"key":"R25-20251014","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/cts.12692","article-title":"Standardizing CYP2D6 genotype to phenotype translation: Consensus recommendations from the clinical pharmacogenetics implementation consortium and Dutch pharmacogenetics working group.","volume":"13","author":"Caudle","year":"2020","journal-title":"Clin Transl Sci."},{"key":"R26-20251014","doi-asserted-by":"crossref","first-page":"e156973","DOI":"10.1172\/jci.insight.156973","article-title":"Modelling buprenorphine reduction of fentanyl-induced respiratory depression.","volume":"7","author":"Olofsen","year":"2022","journal-title":"JCI Insight."},{"key":"R27-20251014","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/j.pain.0000000000000338","article-title":"Translation of random painful stimuli into numerical responses in fibromyalgia and perioperative patients.","volume":"157","author":"Oudejans","year":"2016","journal-title":"Pain."},{"key":"R28-20251014","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/j.1532-2149.2013.00388.x","article-title":"Differences in age-related effects on myelinated and unmyelinated peripheral fibres: A sensitivity and evoked potential study.","volume":"18","author":"Kemp","year":"2014","journal-title":"Eur J Pain."},{"key":"R29-20251014","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.pain.2013.06.041","article-title":"Effect of aging on the cerebral processing of thermal pain in the human brain.","volume":"154","author":"Tseng","year":"2013","journal-title":"Pain."},{"key":"R30-20251014","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.soard.2017.01.015","article-title":"Pain sensitivity and pain scoring in patients with morbid obesity.","volume":"13","author":"Torensma","year":"2017","journal-title":"Surg Obes Relat Dis."},{"key":"R31-20251014","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/00000542-200112000-00009","article-title":"The transfer half-life of morphine-6-glucuronide from plasma to effect site assessed by pupil size measurement in healthy volunteers.","volume":"95","author":"L\u00f6tsch","year":"2001","journal-title":"Anesthesiology."},{"key":"R32-20251014","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1586\/ecp.11.59","article-title":"Pharmacokinetic-pharmacodynamic modeling in acute and chronic pain: An overview of the recent literature.","volume":"4","author":"Martini","year":"2011","journal-title":"Exp Rev Clin Pharmacol."},{"key":"R33-20251014","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/jcph.1075","article-title":"Oliceridine, a novel G protein-biased ligand at the \u03bc-opioid receptor, demonstrates a predictable relationship between plasma concentrations and pain relief. II: Simulation of potential phase 3 study designs using a pharmacokinetic\/pharmacodynamic model.","volume":"58","author":"Fossler","year":"2018","journal-title":"J Clin Pharmacol."},{"key":"R34-20251014","first-page":"434","article-title":"Age-related physiological changes and their clinical significance.","volume":"135","author":"Boss","year":"1981","journal-title":"West J Med."},{"key":"R36-20251014","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0009-9236(96)90058-2","article-title":"Pharmacokinetics of morphine and its glucuronides after intravenous infusion of morphine and morphine-6-glucuronide in healthy volunteers.","volume":"60","author":"L\u00f6tsch","year":"1996","journal-title":"Clin Pharmacol Ther."},{"key":"R37-20251014","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00000542-199701000-00005","article-title":"Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application.","volume":"86","author":"Minto","year":"1997","journal-title":"Anesthesiology."},{"key":"R38-20251014","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0304-3959(97)03363-0","article-title":"The effect of age on the disposition and antinociceptive response of morphine and morphine-6\u03b2-glucuronide in the rat.","volume":"71","author":"van Crugten","year":"1997","journal-title":"Pain."},{"key":"R39-20251014","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/ALN.0b013e3181d5e29d","article-title":"Naloxone reversal of morphine- and morphine-6-glucuronide-induced respiratory depression in humans.","volume":"212","author":"Olofsen","year":"2010","journal-title":"Anesthesiology."},{"key":"R40-20251014","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1521-6896(03)00008-9","article-title":"Pharmacodynamics in the elderly.","volume":"17","author":"Vuyk","year":"2003","journal-title":"Best Pract Res Clin Anaesthesiol."},{"key":"R41-20251014","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.amjopharm.2007.10.001","article-title":"Pharmacodynamics in older adults: A review.","volume":"5","author":"Bowie","year":"2007","journal-title":"Am J Geriatr Pharmacother."},{"key":"R42-20251014","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0009-9236(03)00152-8","article-title":"Side effects of opioids during short-term administration: Effect of age, gender and race.","volume":"74","author":"Cepeda","year":"2003","journal-title":"Clin Pharmacol Ther."},{"key":"R43-20251014","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0022-3565(25)22695-7","article-title":"Decreased fentanyl and alfentanil dose requirements with age; a simultaneous pharmacokinetic and pharmacodynamic evaluation.","volume":"240","author":"Scott","year":"1987","journal-title":"J Pharmacol Exp Ther."},{"key":"R44-20251014","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/ALN.0000000000002184","article-title":"Averting opioid-induced respiratory depression without affecting analgesia.","volume":"128","author":"Dahan","year":"2018","journal-title":"Anesthesiology."},{"key":"R45-20251014","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1113\/jphysiol.1990.sp018043","article-title":"On a pseudo-rebreathing technique to assess the ventilatory sensitivity to carbon dioxide in man.","volume":"423","author":"Dahan","year":"1990","journal-title":"J Physiol."},{"key":"R46-20251014","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1113\/jphysiol.1986.sp016340","article-title":"A pseudo-rebreathing technique for assessing the ventilatory response to carbon dioxide in cats.","volume":"381","author":"Berkenbosch","year":"1986","journal-title":"J Physiol."},{"key":"R47-20251014","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1113\/jphysiol.1989.sp017578","article-title":"The ventilatory CO2 sensitivities from Read\u2019s rebreathing method and the steady-state method are not equal in man.","volume":"411","author":"Berkenbosch","year":"1989","journal-title":"J Physiol."},{"key":"R48-20251014","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1113\/jphysiol.1989.sp017883","article-title":"The steady-state and rebreathing methods compared during morphine administration in humans.","volume":"419","author":"Bourke","year":"1989","journal-title":"J Physiol."}],"container-title":["Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.asahq.org\/anesthesiology\/article-pdf\/138\/3\/249\/691730\/20230300.0-00010.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.lww.com\/10.1097\/ALN.0000000000004473","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T15:44:14Z","timestamp":1760456654000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ALN.0000000000004473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,20]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/aln.0000000000004473","relation":{},"ISSN":["0003-3022","1528-1175"],"issn-type":[{"value":"0003-3022","type":"print"},{"value":"1528-1175","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,20]]}}}